Skip to main content
. 2019 Aug 6;12:6203–6216. doi: 10.2147/OTT.S213833

Table 1.

Compare between ELMO1-AS1 expression and clinicopathological characteristics in HCC patients

Training set Validation set Combined set
Clinicopathologic Parameters Total (n=110) Low (n=55) High (n=55) P-value Total (n=112) Low (n=56) High (n=56) P-value Total (n=222) Low (n=111) High (n=111) P-value
Gender 0.801 0.341 0.239
 Female 19 9 10 11 4 7 30 12 18
 Male 91 46 45 101 52 49 192 99 93
Age (years) 0.057 0.280 1.000
 <55 88 40 48 96 50 46 184 92 92
 ≥55 22 15 7 16 6 10 38 19 19
Tumor number 0.606 0.645 0.304
 <3 92 47 45 88 43 45 180 93 87
 ≥3 18 8 10 24 13 11 42 18 21
Tumor diameter 0.189 0.357 0.113
 <5 cm 28 11 17 24 10 14 52 21 31
 ≥5 cm 82 44 38 88 46 42 170 90 80
AFP 1.000 0.057 0.178
 <400 ng/ml 58 29 29 50 20 30 108 49 59
 ≥400 ng/ml 52 26 26 62 36 26 114 62 52
PVTT 0.039 1.000 0.178
 No 97 45 52 94 47 47 191 92 99
 Yes 13 10 3 18 9 9 31 19 12
Microsatellite 0.185 0.324 0.239
 No 100 48 52 92 44 48 192 93 99
 Yes 10 7 3 20 12 8 30 18 12
MVI 0.340 0.038 0.060
 No 55 25 30 55 22 33 110 48 62
 Yes 55 30 25 57 34 23 112 63 49
TNM stage 0.152 0.287 0.139
 I+II 75 34 41 72 34 38 147 69 78
 III+IV 35 21 14 38 22 16 73 42 31

Abbreviations: AFP, alpha-fetoprotein; PVTT, portal vein tumor thrombus; MVI, microvascular invasion.